Prime Movers

The Future of Animal Health w/ Dalan Animal Health CEO Annette Kleiser

In this episode of Prime Movers, host Gavin Mathis welcomes Annette Kleiser, CEO and founder of Dalan Animal Health, to discuss her journey from scientist to entrepreneur and the critical issue of honeybee health. Annette shares her origin story and her passion for addressing the alarming decline in honeybee populations, which are essential for global food security. She emphasizes the importance of honeybees in pollinating a significant portion of the world's food crops and highlights the multifaceted challenges they face, including diseases, climate change, and pesticides. The conversation delves into Dalan's innovative approach to developing vaccines for honeybees, a groundbreaking solution that could revolutionize bee health management. Annette explains the science behind the bee's innate immune system and how her team has successfully developed a vaccine that protects colonies from disease. She shares early trial results, showcasing the positive impact of the vaccine on bee health and productivity, and discusses the potential for similar applications in other species, such as shrimp. The episode concludes with Annette's insights on the future of animal health and the importance of innovative solutions in addressing global challenges. Chapters 00:00 Introduction to Annette Kleiser and Dalan Animal Health 03:29 The Importance of Honeybees and the Problem of Colony Collapse 08:33 Innovative Solutions: Developing Vaccines for Honeybees 14:04 Field Trials and Early Results of the Bee Vaccine 18:45 Expanding Horizons: Vaccination in Shrimp and Other Species 24:21 Challenges and Insights from Founding Dalan Animal Health 29:32 Future Predictions and the Vision for Animal Health

Revolutionizing Tissue Therapeutics w/ Dimension Bio CEO Caralynn Nowinski Collens, M.D.

Dimension Bio CEO Caralynn Nowinski Collens, M.D., discusses the company's mission to create life-saving regenerative therapies, particularly for liver disease. She shares her journey in the startup world, the increasing demand for liver treatments, and the innovative approaches Dimension Bio is taking with cell-based therapies. The conversation also touches on recent advancements, regulatory challenges, and future predictions for the field of regenerative medicine. Chapters 00:00 Introduction to Dimension Bio and Its Mission 02:39 Caralynn's Journey and Leadership in Startups 05:13 The Growing Need for Liver Disease Treatments 08:23 Understanding Cell-Based Therapies 11:15 Recent Milestones and Innovations in Therapy 14:03 The Mechanism of Action and Placement of Therapies 16:59 Regulatory Landscape and Future Predictions 19:40 Final Thoughts and Future Aspirations

The Future of Geothermal Energy and Desalination w/ Aaron Mandell

Wacomet and Polpis Founder and CEO Aaron Mandell discusses his journey as a founder of multiple companies focused on geothermal energy and desalination. He shares insights on the potential of geothermal energy in the U.S., the challenges of scaling it, and the importance of desalination as a critical resource for water management. Mandell advocates for a national water strategy to address the growing water crisis and emphasizes the need for innovative financing solutions to support desalination projects. He reflects on the lessons learned throughout his entrepreneurial journey and the importance of believing in the potential for technological advancements to transform industries. Chapters 00:00 - The Journey of a Repeat Founder 03:02 - Innovations in Geothermal Energy 06:05 - Scaling Geothermal: Opportunities and Challenges 09:06 - Site Selection for Geothermal Resources 12:12 - Desalination: A Critical Resource 14:55 - Advocating for a National Water Strategy 20:07 - The Future of Water Management 25:07 - Financing Desalination Projects 27:49 - Lessons from the Founder Journey 30:57 - Looking Ahead: Breakthroughs in Energy and Water 33:01 - Inspiration and Recommendations Books mentioned: * Cadillac Desert [https://www.amazon.com/Cadillac-Desert-American-Disappearing-Revised/dp/0140178244] by Marc Reisner * Hillbilly Elegy: A Memoir of a Family and Culture in Crisis [https://www.amazon.com/Hillbilly-Elegy-Memoir-Family-Culture/dp/0062300555/ref=sr_1_1?crid=N3KDQ8C1VRI3&dib=eyJ2IjoiMSJ9.8sLR342bZnl_mard_P-ZDHyYe-rXGa_7_MD0DjvbtSIP0cTvy4D6rIhNribq4oXriLXRVboXeuMLkWsH21SgMlyS3QC7kd8lsC-FEKgQ0b-jrmnAnWQt81BxmaDLRc9ZzAB9EDiIcMHjfsNFxvf7L-e9GscrbM47VRvxK5Ol8D__l-fqA5bZd088EsrfrBPekQ-J-VgRouvMiqYyfvo3CqCTI2HGH84TEcR2eQ2lC4I.4U_HkpLUWJfycdd-RUcmUi5ATKvTyfkz4oSTyUh7HAs&dib_tag=se&keywords=hillbilly+elegy+by+j.d.+vance&qid=1745342037&s=books&sprefix=hillbilly+eleg%2Cstripbooks%2C356&sr=1-1] by JD Vance * Tryptamine Palace: 5-MeO-DMT and the Sonoran Desert Toad [https://www.amazon.com/Tryptamine-Palace-5-MeO-DMT-Sonoran-Desert/dp/1594772991] by James Oroc

Harnessing the Power of Fusion Energy w/ Focused Energy CEO Scott Mercer

In this episode of the Prime Rovers podcast, Focused Energy CEO Scott Mercer discusses his journey in the energy sector and the advancements in fusion energy. He explains the unique approach of laser fusion technology, the commercialization process, and the regulatory environment surrounding fusion compared to fission. Scott emphasizes the importance of energy abundance for global progress and the bipartisan support for fusion initiatives. He also shares personal insights on the challenges of being a founder and his predictions for the future of energy. Chapters 00:00 Introduction to Scott Mercer and Focus Energy 02:51 The Evolution of Fusion Energy 06:04 Understanding Laser Fusion Technology 08:53 Commercialization of Fusion Energy 12:13 Fusion's Role in Global Energy Demand 14:54 Regulatory Environment for Fusion vs. Fission 18:08 Bipartisan Support and Industrial Policy for Fusion 20:57 Personal Insights and Future Predictions

Future of Regenerative Medicine w/ LyGenesis CEO Michael Hufford

LyGenesis CEO Michael Hufford joins Prime Movers Lab Partner Gavin Mathis to discuss Michael's extensive background in drug development and the innovative work being done at LyGenesis in regenerative medicine. The company has found a way to turn lymph nodes into bioreactors to grow functioning ectopic organs, particularly the liver. Michael shares insights into their clinical trials, the economic implications of their therapies, and the broader applications of their technology. He also addresses the regulatory landscape and personal reflections on the challenges and future of regenerative medicine. Chapters 00:00 Introduction to LightGenesis and Michael Hufford 03:53 Innovative Approaches in Regenerative Medicine 10:00 Clinical Trials and Liver Regeneration 15:11 Economic Impact of Liver Therapy 19:50 Expanding Applications Beyond the Liver 24:52 Regulatory Landscape and Challenges 29:03 Personal Insights and Future Predictions